CJC-1295 + Ipamorelin | Two Signals, One Synergistic Effect
You train consistently, take recovery seriously, and you’re in this for the long haul. This stack is built for exactly that – giving your body the hormonal environment it needs to keep up with everything you’re asking of it.
CJC-1295 and Ipamorelin are both growth hormone-stimulating peptides. But they act on different receptors: CJC-1295 is a long-acting GHRH analog, while Ipamorelin acts on the growth hormone-releasing peptide (ghrelin) receptor. This exact pair has not yet been tested in clinical trials, but in human studies combining these two classes of signal released growth hormone synergistically.12
Think of it this way: Ipamorelin triggers a short pulse of growth hormone. CJC-1295 lasts for days and raises background growth hormone levels while your natural pulses continue. Because your pituitary still does the releasing, output stays under your body’s own controls rather than being overridden.34
Within the Peak Performance Suite, this is the stack we reach for when patients are ready to go further – whether that means stepping into it as a primary protocol or building on an existing growth hormone optimization plan.
What Our Patients Notice
What patients typically report
Most patients begin noticing changes within 4-8 weeks. Here’s what patients commonly report.
I’m recovering between sessions like I used to.
Faster, more complete recovery is the most consistent feedback we hear. Recovery benefits have not yet been measured in clinical studies of these peptides, and recovery still depends on sleep, training load, and nutrition.
My body composition is actually shifting.
Raising growth hormone activity can shift body composition: in a randomized trial of a GHRH analog in abdominally obese adults with low growth hormone, visceral fat fell. CJC-1295 + Ipamorelin itself has not yet been tested this way, and results vary between patients. However, anecdotally, positive patient outcomes are noted.56
I’m building muscle again.
Raising growth hormone increases lean body mass in trials, although added strength has not been consistently shown. Many patients tell us their training feels more productive.78
My sleep is on another level.
Growth hormone release rises sharply during deep sleep, and the amount released tracks with how much deep sleep you get. Some patients report better sleep on this protocol, though that has not yet been studied in trials.910
My energy and focus are sharper.
The mental side of performance matters too. Some patients report clearer thinking, steadier energy, and more drive, although these effects have not yet been studied in clinical trials of CJC-1295 or Ipamorelin.
Long-term resilience you’re building right now.
In adults with diagnosed growth hormone deficiency, treatment benefits body composition, exercise capacity, and skeletal integrity. In healthy older adults, growth hormone did not improve bone density in trials, and long-term benefits of these peptides are unknown.116 This isn’t just about how you perform this month – it’s about staying in the game for the long haul.
Does This Sound Like You?
CJC-1295 + Ipamorelin tends to be a strong fit for men and women over 35 who are performance-focused, active, and frustrated that their body isn’t keeping pace with their effort and commitment.
You might be a good candidate if you:
Train consistently but feel like your recovery has slowed significantly
Are putting in the work but not seeing the body composition results you used to
Wake up feeling like you never fully recovered from the day before
Have noticed a drop in energy, drive, or mental sharpness that you can’t explain
Want a protocol designed for long-term performance, not a quick fix
Are ready to move into a comprehensive growth hormone optimization program
Dr. Varano or his Medical Provider Team will review your labs, symptoms, and goals before any protocol is recommended – nothing is prescribed without a full clinical picture.
Our Foundational Assessment is where it starts. It gives us – and you – everything we need to build the right plan.
The YoungerMeMD CJC-1295 + Ipamorelin Program
Every CJC-1295 + Ipamorelin protocol follows the same three steps, so you know the full cost before you start.
STEP 1
Foundational Assessment
$599one-time
Your starting point is a comprehensive, 1-hour deep dive:
Amplified results for body composition, recovery, and performance.
A small subcutaneous injection, typically in the abdomen, given at home before bed
Prescribed only after a full evaluation of your labs and history
Adjusted over time as part of your membership
How is it taken?
It’s a subcutaneous injection – small needle, typically in the abdomen – given at home before bed. Our YoungerMeTeam walks you through everything and stays available for questions as you get started.
How soon will I notice something?
Sleep and recovery improvements often show up within the first few weeks. Body composition and energy changes build over 4-8 weeks, with the most significant results typically coming at the 3-6 month mark with consistent use.
Is it safe?
Both peptides work within your body’s own regulatory systems – there is no external growth hormone introduced – and short-term studies found each generally well tolerated. Human data are limited, however, and long-term safety has not been established.1213 At YoungerMeMD, this protocol is never prescribed without a full evaluation by Dr. Varano.
Can it be combined with other peptides or hormones?
Absolutely. CJC-1295 + Ipamorelin fits naturally within a broader hormone optimization protocol and can be incorporated alongside BHRT or other peptide programs depending on your goals and where you are in your health journey. Every protocol is built individually – nothing is stacked without clinical justification from your Provider.
Is this covered by insurance?
CJC-1295 + Ipamorelin is offered through YoungerMeMD’s membership-based model, which operates outside of traditional insurance. Your membership includes physician oversight, ongoing protocol management, and the personalized attention that insurance-based care isn’t designed to provide.
Why use two peptides together?
CJC-1295 and Ipamorelin work through different pathways. Ipamorelin triggers a short growth hormone pulse, while long-acting CJC-1295 raises baseline growth hormone with natural pulses preserved. The combination itself has not yet been studied in clinical trials.34
Is this the same as taking growth hormone?
No. Both peptides work within your body’s own regulatory systems and no external growth hormone is introduced123, and the protocol is only prescribed after a full clinical evaluation.
The version of you that recovers fast, builds lean, sleeps deep, and performs at a high level year after year – that’s not behind you. It’s what this protocol is designed to help you get back to.
CJC-1295 + Ipamorelin is one of the most effective tools we have for patients who are serious about performance and longevity. And it starts with understanding your full picture.
Book a Peptide Consult and let’s look at what your labs are telling us. From there, Dr. Varano will build a protocol that fits your goals, your body, and how you want to live.
Bowers CY, Reynolds GA, Durham D, et al. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab 1990. PMID 2108187 · doi:10.1210/jcem-70-4-975↩
Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol 1998. PMID 9849822 · doi:10.1530/eje.0.1390552↩
Gobburu JV, Agersø H, Jusko WJ, et al. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharm Res 1999. PMID 10496658 · doi:10.1023/a:1018955126402↩
Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab 2006. PMID 17018654 · doi:10.1210/jc.2006-1702↩
Makimura H, Feldpausch MN, Rope AM, et al. Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial. J Clin Endocrinol Metab 2012. PMID 23015655 · PMC3513535 · doi:10.1210/jc.2012-2794↩
Veldhuis JD, Iranmanesh A. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and sleep. Sleep 1996. PMID 9085516 · doi:10.1093/sleep/19.suppl_10.s221↩
Van Cauter E, Leproult R, Plat L. Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA 2000. PMID 10938176 · doi:10.1001/jama.284.7.861↩
Molitch ME, Clemmons DR, Malozowski S, et al. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011. PMID 21602453 · doi:10.1210/jc.2011-0179↩
Teichman SL, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab 2006. PMID 16352683 · doi:10.1210/jc.2005-1536↩
Beck DE, Sweeney WB, McCarter MD. Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Int J Colorectal Dis 2014. PMID 25331030 · doi:10.1007/s00384-014-2030-8↩
Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.
What It Evaluates
Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:
Gluten sensitivity
Celiac-associated antibodies
Non-celiac wheat sensitivity
Gut barrier integrity ("leaky gut")
Autoimmune-triggering peptides
Conditions We Identify
Chronic bloating
Fatigue after eating
Brain fog
Skin rashes
Joint pain
Autoimmune symptoms
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.